SCHEMBL3124612

SCHEMBL3124612

CCOc1ccc(S(=O)(=O)N2CCN(C)CC2)cc1B(O)O

nearest known ligand 0.62

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.62
KDM4E B2RXH2 1/20 0.62
ALDH1A1 P00352 3/20 0.57
LMNA P02545 2/20 0.57
HTT P42858 1/20 0.57
SMN1; SMN2 Q16637 1/20 0.57
MEN1 O00255 1/20 0.56
KMT2A Q03164 1/20 0.56
POLB P06746 1/20 0.54
CYP2C9 P11712 1/20 0.53
L3MBTL1 Q9Y468 1/20 0.52
CA12 O43570 2/20 0.52
CA9 Q16790 2/20 0.52
RAB9A P51151 1/20 0.51
PDE5A O76074 2/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29285658 0.85 L3MBTL1 (0.67) TSHRKDM4EALDH1A1LMNASMN1; SMN2
SCHEMBL4264787 0.84 TSHR (0.60) TSHRKDM4EALDH1A1LMNAHTT
SCHEMBL5826839 0.84 TSHR (0.60) TSHRKDM4EALDH1A1LMNAHTT
SCHEMBL3131935 0.83 TSHR (0.63) TSHRKDM4EALDH1A1LMNAHTT
SCHEMBL4551788 0.82 POLB (0.60) TSHRKDM4EALDH1A1LMNAHTT
Hydrochloric Acid SCHEMBL6196657 0.81 POLB (0.61) TSHRKDM4EALDH1A1LMNAHTT
SCHEMBL5875796 0.81 MEN1 (0.60) TSHRKDM4EALDH1A1LMNAHTT
SCHEMBL5875625 0.81 TSHR (0.57) TSHRKDM4EALDH1A1LMNAHTT
SCHEMBL5827157 0.81 CYP2C9 (0.65) TSHRKDM4EALDH1A1LMNAHTT
SCHEMBL6993844 0.81 POLB (0.61) TSHRKDM4EALDH1A1LMNAHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2168967-A1 INTERMEDIATES FOR PREPARATION OF AN INHIBITOR OF PHOSPHODIESTERASE TYPE 5 Galenicum Health, S.l. (ES) 2010-03-31 EP claimed
EP-2168967-A1 INTERMEDIATES FOR PREPARATION OF AN INHIBITOR OF PHOSPHODIESTERASE TYPE 5 Galenicum Health, S.l. (ES) 2010-03-31 EP disclosed